ResMed | RMD - Operating Profit


ResMed reported $454.34M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
Ansell USD 146.5M 87.85M Dec/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 4.35M 5.31M Sep/2026
Baxter International USD 314M 38M Sep/2026
Cochlear AUD 261.1M 135.55M Dec/2025
Cooper Companies USD 222M 253M Jun/2026
CSL USD 2.64B 1.97B Dec/2025
Dexcom USD 318.3M 63M Jun/2026
Edwards Lifesciences USD 542.7M 23.2M Sep/2026
Fisher Paykel Healthcare NZD 368.8M 70.6M Jun/2026
Globus Medical USD 178.23M 224.2M Sep/2026
Haemonetics USD 75.12M 17.66M Sep/2026
Idexx Laboratories USD 402.35M 23.22M Sep/2026
Inogen USD -7.79M 728K Sep/2024
Insulet USD 189.8M 60.1M Sep/2026
Integra LifeSciences USD 42.65M 1.36M Sep/2026
Intuitive Surgical USD 1.05B 69.9M Sep/2026
Medtronic USD 1.84B 254M Jun/2026
Philips EUR 165M 445M Sep/2026
Ramsay Health Care AUD 541.1M 3.9M Dec/2025
ResMed USD 454.34M 51.33M Jun/2026
Sigma Healthcare AUD 809K 13.76M Dec/2024
Sonic Healthcare AUD 435.76M 193.66M Dec/2024
Steris USD 319.2M 33.4M Sep/2026
Teleflex USD -105.77M 178.84M Sep/2026
Thermo Fisher Scientific USD 2.46B 277M Sep/2026